About this episode
European Biopharmaceuticals Analyst Justin Smith joins host Diana Wood to discuss the heartbreaking and challenging world of Alzheimer’s. Here, they discuss the causes, symptoms and diagnosis, and delve into drug development. A devastating condition for patients and family members, Justin discusses his optimistic view on the future, referencing Roche’s innovation in the space and brain shuttle model, as well as clinical trials thus far.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time In the Know publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from In the Know
Rupal Agarwal: Gen AI in Asset Management
In the Know
Apr 1, 202630:44failed
Jay Huang: The Dawn of the Next Robot Age
In the Know
Mar 17, 202626:28failed
Will Pickering: FDA Under Trump, A New Era of Regulation
In the Know
Mar 3, 202633:38pending
Will Kirkness: Rentokil, A Century of Pest Control
In the Know
Feb 17, 202630:48pending